RNAi is a novel and innovative approach to specifically target and silence any gene involved in the cause or pathway of disease.
RNAi, a Promising Potential New Class of Medicines
Video Aug 10, 2017 | Original video from Alnylam Pharmaceuticals YouTube Channel
Study Shows HPV-vaccine Against Cervical Cancer is WorkingVideo
Girls in the first birth cohort to be offered and receive the HPV vaccine showed a lower degree of dysplasia which may eventually lead to cervical cancer than a birth cohort from 1983. This is the conclusion of a new study conducted by researchers at the University of Copenhagen, who have been the first to study the vaccine’s effect on the general population.WATCH NOW
Targeting Tumors: Challenges of Antibody-Drug ConjugatesVideo
More than two dozen ADCs are currently being used in the clinic to treat diseases like Hodgkin's lymphoma and breast cancer, and researchers are developing many more. But it's taken decades to find the right combination of drug, antibody target and linker, and then make sure the right amount of ADC hits the tumor.